Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Dexmedetomidine for Delirium Prevention in ICU
NCT03172897Phase 4Suspended
- Sponsor
- Peking University First Hospital
- Start
- Aug 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in delirium, sponsored by Peking University First Hospital. Started Aug 2017; status: suspended.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03172897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172897.